Abstract
Mitochondrial dysfunction has long been considered in the pathogenesis of Parkinson's disease (PD). This can be evident from the presence of mitochondrial DNA deletions in substantia nigra neurons and respiratory chain abnormalities in the skeletal muscle of PD patients. However, the contributing factors that potentially cause oxidative stress in PD are still elusive. To a certain extent, the identification of acquired changes in circulating mitochondrial DNA (mtDNA) content in blood samples may mirror the mitochondrial (dys-) function. Therefore, herein, we investigated the mtDNA concentrations in serum and cerebrospinal fluid (CSF) of PD patients. Our quantitative analysis (qPCR) at two mitochondrial regions (D-Loop; ATPase6) revealed an increase in mtDNA serum concentrations in PD females compared to healthy females. Of particular interest, these altered concentrations were restricted to females serum only. Thus, in males as well as CSF of PD patients no increase was detected. In addition, we evaluated mtDNA methylation in the platelets isolated from plasma of PD patients by bisulfite-PCR pyrosequencing. The analysis did not reveal any altered platelet mtDNA methylation levels at MT-TL1 and MT-CO1 mitochondrial regions. In addition, total lack of platelet mtDNA methylation was observed at MT-CO2 and MT-CO3 mitochondrial sites. Taken together, we found an increased mtDNA serum concentration exclusively in PD females. As of yet, it is unclear whether this might reflect specific changes or characteristics of female PD pathobiology. However, in context to the ongoing debate about mtDNA methylation, we could show that the mitochondrial epigenome do harbors detectable CpG methylation sites in platelets-derived DNA.